|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.38 CNY | -3.45% |
|
+9.54% | +2.06% |
| 07-14 | Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 06-16 | Tasly Subsidiary Gets China Approval for Hypertension Drug | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -3.45% | +9.54% | +8.23% | +6.66% | +2.06% | -3.88% | +11.29% | +11.61% | -45.21% | 3.51B | |
| -1.32% | +6.33% | +4.07% | -7.38% | -9.41% | -8.03% | -5.29% | -31.22% | +2.55% | 13.73B | |
| -3.30% | +12.63% | +6.85% | -6.80% | -19.28% | -26.94% | -50.04% | -29.34% | -20.10% | 5.45B | |
| -2.47% | +7.12% | +4.50% | -9.89% | +2.14% | +1.38% | -2.05% | +42.41% | -14.38% | 4.84B | |
| -5.06% | +8.62% | +9.20% | -3.85% | -3.34% | +9.27% | -34.00% | -12.42% | +31.70% | 4.29B | |
| -2.65% | -5.70% | -0.84% | -7.87% | -16.90% | +5.95% | -5.37% | +47.45% | +106.82% | 3.85B | |
| 0.00% | +8.92% | -1.24% | +4.00% | -0.19% | -5.20% | -4.44% | +60.85% | -7.99% | 3.57B | |
| -3.77% | -0.32% | -0.26% | -7.77% | -0.51% | -12.63% | -22.78% | -28.36% | - | 2.52B | |
| -2.82% | +2.80% | +8.37% | +5.46% | +8.16% | -1.62% | +50.74% | +111.12% | +90.64% | 1.92B | |
| -4.32% | +5.21% | +3.14% | -10.32% | -11.16% | -7.24% | -10.40% | -28.14% | -28.63% | 1.84B | |
| -2.95% | +5.16% | +3.88% | -13.36% | -4.04% | -6.35% | -23.57% | -5.73% | -38.51% | 1.65B | |
| -5.90% | +4.13% | +5.40% | -12.82% | -14.17% | -25.27% | +19.36% | +60.72% | +44.03% | 1.51B | |
| -4.37% | +6.15% | +7.19% | -9.89% | -6.82% | -18.41% | -37.64% | -23.90% | -46.35% | 1.52B | |
| -6.52% | +11.76% | +13.44% | -7.29% | +3.44% | -20.86% | -27.70% | -7.57% | -63.66% | 1.21B | |
| -2.69% | +1.75% | +8.06% | -6.75% | -4.96% | -10.31% | -19.28% | +0.83% | -31.56% | 1.19B | |
| -1.23% | +9.91% | +9.91% | +10.09% | -7.65% | -15.80% | -38.61% | -15.65% | -39.38% | 1.19B | |
| -4.87% | +9.30% | +8.75% | -13.41% | -16.35% | -25.69% | -53.89% | -66.32% | -31.23% | 1.14B | |
| +1.03% | +1.03% | +4.26% | +5.95% | +8.89% | +39.50% | +59.35% | -57.06% | +1,300.00% | 1.03B | |
| -4.26% | +1.35% | +2.27% | -10.36% | +3.45% | -16.97% | -46.36% | -36.62% | -76.86% | 947M | |
| -5.87% | -30.52% | -31.34% | -34.29% | -29.45% | -21.52% | +25.64% | -18.63% | -57.11% | 666M | |
| Average | -3.34% | +0.69% | +3.69% | -6.49% | -5.80% | -8.53% | -10.75% | -1.30% | +56.57% | 2.88B | |
| Weighted average by Cap. | -2.78% | +2.26% | +4.44% | -5.67% | -6.57% | -7.30% | -11.70% | -1.19% | +23.67% |
- Stock Market
- Stocks
- 600535 Stock
- Sector Tasly Pharmaceutical Group Co., Ltd
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
